Nagai H, Matsunaga M, Ogawa K, Pak C H, Kanatsu K, Hara A, Kono T, Kawai C
Clin Exp Pharmacol Physiol. 1986 Jan;13(1):69-75. doi: 10.1111/j.1440-1681.1986.tb00317.x.
Changes in plasma active and inactive renin concentration (ARC and IRC) after captopril administration and angiotensin II (AII) infusion were studied in six patients with Bartter's syndrome. A single oral dose of captopril (8-25 mg) lowered the blood pressure and increased both ARC and IRC. AII infusion elevated blood pressure, suppressed ARC and increased IRC. In this syndrome of high renin levels, infused AII appeared to increase inactive renin secretion by reducing its conversion to active renin. On the other hand, an acute fall in AII levels and/or renal perfusion pressure by captopril increased both active and inactive renin. This indicates that the increase in the secretion of inactive renin, stimulated by captopril, might exceed any increase in its conversion to active renin in patients with Bartter's syndrome, in whom the production of renin is accelerated, and conversion of inactive renin to active renin probably already operates near its maximum.
对6例巴特综合征患者研究了服用卡托普利及输注血管紧张素II(AII)后血浆活性和非活性肾素浓度(ARC和IRC)的变化。单次口服卡托普利(8 - 25毫克)可降低血压,并使ARC和IRC均升高。输注AII可升高血压,抑制ARC并增加IRC。在这种高肾素水平综合征中,输注的AII似乎通过减少其向活性肾素的转化来增加非活性肾素分泌。另一方面,卡托普利使AII水平和/或肾灌注压急性下降,使活性和非活性肾素均增加。这表明,在肾素产生加速且非活性肾素向活性肾素的转化可能已接近最大程度的巴特综合征患者中,卡托普利刺激的非活性肾素分泌增加可能超过其向活性肾素转化的任何增加。